EUVIMEDEUVIMED entdecken
Crossref

The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans

Jonathan N Bauman, Angela C Doran, Gabrielle M Gualtieri, Brian Hee, Timothy Strelevitz, Matthew A Cerny iD, Christopher Banfield, Anna Plotka, Xiaoxing Wang, Vivek S Purohit, Martin E Dowty iD

Drug Metabolism and Disposition · 2024-10 · 52 (10) · 1124-1136

DOI: 10.1124/dmd.124.001843 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2024-10. Verfasst von Jonathan N Bauman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S.…. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Kinase InhibitorsHumansMaleAdultJanus Kinase 3Administration, OralYoung AdultProtein-Tyrosine KinasesMetabolic Clearance RateMiddle AgedBiological AvailabilityHalf-LifeAdministration, Intravenous

Substanzen

Protein Kinase InhibitorsJanus Kinase 3Protein-Tyrosine Kinases

Autor:innen und Institutionen

  • Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C…

ORCID-Profile: Matthew A Cerny, Martin E Dowty

Zitieren

APA

Bauman, J. N., Doran, A. C., Gualtieri, G. M., Hee, B., Strelevitz, T., Cerny, M. A., Banfield, C., Plotka, A., Wang, X., Purohit, V. S., & Dowty, M. E. (2024). The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans. Drug Metabolism and Disposition, 52(10), 1124-1136. https://doi.org/10.1124/dmd.124.001843

Vancouver

Bauman JN, Doran AC, Gualtieri GM, Hee B, Strelevitz T, Cerny MA, et al. The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans. Drug Metabolism and Disposition. 2024;52(10):1124-1136. doi:10.1124/dmd.124.001843

BibTeX
@article{Bauman2024,
  author = {Bauman, Jonathan N and Doran, Angela C and Gualtieri, Gabrielle M and Hee, Brian and Strelevitz, Timothy and Cerny, Matthew A and Banfield, Christopher and Plotka, Anna and Wang, Xiaoxing and Purohit, Vivek S and Dowty, Martin E},
  title = {The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans},
  journal = {Drug Metabolism and Disposition},
  year = {2024},
  volume = {52},
  number = {10},
  pages = {1124--1136},
  doi = {10.1124/dmd.124.001843}
}
Kostenlos starten →